Biogen logo

Co-op, Parenteral Drug Product Development

Biogen
Remote friendly (Cambridge, MA)
United States
Operations

Role Summary

As a Co-op in Parenteral Drug Product Development, you will contribute to the study and testing of oligonucleotides across diverse formulations and steam sterilization conditions. This role offers hands-on experience in formulation science and sterilization techniques and opportunities to contribute to internal reports as a co-author. You will immerse yourself in departmental meetings to gain a comprehensive understanding of oligonucleotide drug product development within the pharmaceutical industry, and you will present your research findings in both oral and written formats, collaborating with a pharmaceutical scientist on a project that advances development efforts.

Responsibilities

  • Planning and executing research related to the development of steam-sterilization process
  • Utilization of a variety of physical and chemical characterization techniques to develop an understanding of the physicochemical characteristics of oligonucleotides and associated formulations.
  • Utilization of modeling tools to assess formulation stability and performance
  • Development of small-scale pre-formulation screening workflow to predict formulation performance

Qualifications

  • Required: Basic laboratory skills and research experience, such as recording in lab notebook, aseptic manufacturing techniques (buffer exchange, filtration, sterilization), analytical techniques (ultra high-pressure liquid chromatography, spectroscopy), and safe lab practices.
  • Preferred: Knowledge of synthetic oligonucleotides development (chemistry, manufacturing, and controls) and statistical analysis by JMP.
  • Required: Legal authorization to work in the U.S.; At least 18 years of age prior to the scheduled start date; Currently enrolled in an accredited college, college, university or skills program/apprenticeship.

Education

  • Bachelor's degree (Junior / Senior), or graduate student pursuing Masters
  • Must have completed a minimum of two years of study toward a bachelor’s degree by May 2026.
  • Preferred majors/programs: Pharmacy, Pharmaceutics, Pharmaceutical Sciences, Analytical Chemistry, or related disciplines